Beryl Crossly

Quest Diagnostics (United States)

Papers

1

Total Citations

6

H-Index

1

About

Beryl Crossly is a genetic researcher whose work has significantly advanced the understanding and diagnosis of rare lysosomal storage disorders, particularly within the Ashkenazi Jewish population. Her most cited study, "Rapid One-Step Carrier Detection Assay of Mucolipidosis IV Mutations in the Ashkenazi Jewish Population" (2006), introduced a streamlined, high-throughput method for identifying carriers of Mucolipidosis IV (MLIV), a severe neurodegenerative condition. This assay, which has garnered 6 citations, provided a critical tool for genetic screening, enabling faster and more accessible carrier detection in a community with a high prevalence of the disease. Crossly’s contribution lies in bridging the gap between molecular genetics and clinical application, offering a practical solution for prenatal and carrier testing that reduces the burden of MLIV. Her work exemplifies how targeted, population-specific assays can improve public health outcomes, and it remains a foundational reference for researchers developing similar diagnostic approaches for other founder mutations.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Rapid One-Step Carrier Detection Assay of Mucolipidosis IV Mutations in the Ashkenazi Jewish Population
6 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago